81
edits
Supply Chain Issues: Difference between revisions
→Common Supply Chain Challenges during the Pandemic
No edit summary |
|||
| (One intermediate revision by the same user not shown) | |||
| Line 24: | Line 24: | ||
Asthma and COPD medications, such as albuterol inhalers. | Asthma and COPD medications, such as albuterol inhalers. | ||
==== Personal protective equipment (PPE) | ==== Personal protective equipment (PPE)==== | ||
Masks, N95 respirators and surgical masks crucial for healthcare workers. | |||
====Hand Sanitiser==== | |||
Medical-grade hand sanitisers and alcohol-based hand sanitiser recommended by the World Health Organisation (WHO) for their effectiveness in killing bacteria. The extreme shortage led some distilleries to start production of their own brands of hand sanitiser, and a relaxation in regulation to allow for rapid production and distribution. | |||
===Ongoing Supply Chain Challenges=== | ===Ongoing Supply Chain Challenges=== | ||
| Line 67: | Line 70: | ||
''' | ''' | ||
Routine vaccines, such as flu vaccines, were in short supply due to the focus and attention shifting to COVID-19 vaccine production. | Routine vaccines, such as flu vaccines, were in short supply due to the focus and attention shifting to COVID-19 vaccine production. | ||
===Long-term Changes in Medical Supply Chains=== | |||
Different countries responded to the pandemic with varying levels of leadership, governance, and preparedness. Public health measures and government communication also differed significantly. The pandemic is leading to changes in how supplies are produced and distributed based on what was learned from these varied approaches. Regulatory frameworks are adapting to factor in precaution and to allow more flexibility in future crises. | |||
There is also learning from from successful initiatives, such as Singapore’s national stockpile of PPE and medical products to last for up to 6 months, drawing on the lessons learned when responding to the SARS (Severe Acute Respiratory Syndrome) outbreak in 2003 <ref>Chua, A. Q. et al. Health system resilience in managing the COVID-19 pandemic: lessons from Singapore. BMJ Glob. Health 5, e003317 (2020). https://gh.bmj.com/content/5/9/e003317 </ref> | |||
==Citations== | ==Citations== | ||
<references/> | <references/> | ||